Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 151,328 | 145,902 | 161,275 | 151,794 | 354,643 |
| Marketable Securities | 659,287 | 725,671 | 776,529 | 847,123 | 699,149 |
| Receivables | 211 | 78 | 286 | 306 | 241 |
| Other current assets | 3,678 | 3,392 | 9,030 | 8,172 | 16,456 |
| TOTAL | $831,798 | $884,349 | $958,388 | $1,019,505 | $1,087,297 |
| Non-Current Assets | |||||
| PPE Net | 10,701 | 11,749 | 11,950 | 11,634 | 11,390 |
| Intangibles | 2,300 | 2,300 | 2,300 | 2,300 | 2,300 |
| Other Non-Current Assets | 62,160 | 63,618 | 64,922 | 66,332 | 67,731 |
| TOTAL | $75,161 | $77,667 | $79,172 | $80,266 | $81,421 |
| Total Assets | $906,959 | $962,016 | $1,037,560 | $1,099,771 | $1,168,718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,353 | 14,778 | 11,834 | 10,578 | 9,485 |
| Accrued Expenses | 31,486 | 26,910 | 28,045 | 22,703 | 29,360 |
| Other current liabilities | 1,100 | 25,263 | 26,147 | 26,152 | 26,901 |
| TOTAL | $50,748 | $71,576 | $70,467 | $63,709 | $71,427 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 24 | 15 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 77,838 | 80,321 | 83,681 | 85,844 | 97,522 |
| TOTAL | $77,838 | $80,321 | $83,681 | $85,844 | $97,522 |
| Total Liabilities | $128,586 | $151,897 | $154,148 | $149,553 | $168,949 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,269 | 122,134 | 121,613 | 121,385 | 120,895 |
| Common Shares | 123 | 122 | 121 | 121 | 121 |
| Retained earnings | -1,317,087 | -1,251,353 | -1,152,848 | -1,058,609 | -991,106 |
| Other shareholders' equity | -3,386 | -6,081 | -5,802 | -10,420 | -13,389 |
| TOTAL | $778,373 | $810,119 | $883,412 | $950,218 | $999,769 |
| Total Liabilities And Equity | $906,959 | $962,016 | $1,037,560 | $1,099,771 | $1,168,718 |